Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06904183
What this trial is testing

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 320
Testing effectiveness (Phase 2)Study completedNCT01572324
What this trial is testing

Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas

Who this might be right for
Biliary Tract Cancer
Peking University 37
Testing effectiveness (Phase 2)UnknownNCT06335927
What this trial is testing

HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 45
Not applicableLooking for participantsNCT07070076
What this trial is testing

A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Li Qiang 286
Large-scale testing (Phase 3)Active Not RecruitingNCT05198609
What this trial is testing

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 214
Testing effectiveness (Phase 2)Ended earlyNCT06370663
What this trial is testing

First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shandong Cancer Hospital and Institute 1
Not applicableWithdrawnNCT04511793
What this trial is testing

Hepatic Artery Infusion (HAI) Program at Duke University

Who this might be right for
Metastatic Colon CancerLiver CancerIntrahepatic Cholangiocarcinoma
Michael Lidsky, M.D.
Early research (Phase 1)Study completedNCT00941499
What this trial is testing

Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 140
Early research (Phase 1)Not Yet RecruitingNCT06283134
What this trial is testing

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
China Medical University, China 60
Testing effectiveness (Phase 2)Study completedNCT05024513
What this trial is testing

Biliary Drainage Plus HAIC in Locally Advanced pCCA

Who this might be right for
Perihilar Cholangiocarcinoma
Peking University 127
Testing effectiveness (Phase 2)Study completedNCT06538623
What this trial is testing

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsNeoplasm MetastasisHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT07594340
What this trial is testing

HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)

Who this might be right for
Hepatocellular Carcinoma
Binkui Li 300
Testing effectiveness (Phase 2)Looking for participantsNCT06741020
What this trial is testing

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhejiang Cancer Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT05476432
What this trial is testing

HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 300
Large-scale testing (Phase 3)Looking for participantsNCT06904170
What this trial is testing

Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
UNICANCER 196
Testing effectiveness (Phase 2)UnknownNCT01224327
What this trial is testing

Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients

Who this might be right for
Liver CirrhosisRadiologyMesenchymal Stem Cells+1 more
Qingdao University 50
Not applicableStudy completedNCT05489692
What this trial is testing

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-sen University 43
Testing effectiveness (Phase 2)Study completedNCT03009461
What this trial is testing

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Thrombosis
Peking University 64
Large-scale testing (Phase 3)Looking for participantsNCT03949231
What this trial is testing

Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Second Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)Looking for participantsNCT07636798
What this trial is testing

Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
West China Hospital 20
Next Page